The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.
During the height of the pandemic, leaving bedside clinical practice crossed my mind. As the darkness of Covid-19 surrounded me, as the death and destruction suffocated me
Alzheimer’s is only one dementia, and there are many others, currently about ten types. The problem is in identifying the individual’s precise dementia and treating it appropriately.